Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction.
about
Induction of stemlike cells with fibrogenic properties by carbon nanotubes and its role in fibrogenesisIdentification of human CCR8 as a CCL18 receptorMechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcomePulmonary vaccination as a novel treatment for lung fibrosisMechanisms of the alternative activation of macrophages and non-coding RNAs in the development of radiation-induced lung fibrosisGene expression profiling offers insights into the role of innate immune signaling in SScModulation of the mevalonate pathway by akt regulates macrophage survival and development of pulmonary fibrosisFlow cytometric analysis of macrophages and dendritic cell subsets in the mouse lungActive transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosisMeta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterialsCannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitisStrain-dependent host transcriptional responses to Toxoplasma infection are largely conserved in mammalian and avian hosts.Monocyte interaction accelerates HCl-induced lung epithelial remodeling.Blockade of IL-6 Trans signaling attenuates pulmonary fibrosisAsbestos-induced disruption of calcium homeostasis induces endoplasmic reticulum stress in macrophagesInflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis.Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.Chlamydia pneumoniae infection in mice induces chronic lung inflammation, iBALT formation, and fibrosis.The role of macrophage IL-10/innate IFN interplay during virus-induced asthma.Spironolactone attenuates bleomycin-induced pulmonary injury partially via modulating mononuclear phagocyte phenotype switching in circulating and alveolar compartments.Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activationChitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis.Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.Functional and phenotypic characteristics of alternative activation induced in human monocytes by interleukin-4 or the parasitic nematode Brugia malayi.Thalidomide inhibits alternative activation of macrophages in vivo and in vitro: a potential mechanism of anti-asthmatic effect of thalidomideCD4-Positive T Cells and M2 Macrophages Dominate the Peritoneal Infiltrate of Patients with Encapsulating Peritoneal Sclerosis.Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.A Mathematical Model of Idiopathic Pulmonary Fibrosis.Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro.Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice15-Lipoxygenases regulate the production of chemokines in human lung macrophages.Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro.Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.Molecular and cellular mechanisms of pulmonary fibrosis.IL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells.Protective role of spleen-derived macrophages in lung inflammation, injury, and fibrosis induced by nitrogen mustard.Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infectionThe Metabolic Prospective and Redox Regulation of Macrophage Polarization.Macrophage heterogeneity in respiratory diseases.
P2860
Q23921932-05DA3368-6BCE-41A5-8BA3-CBC070987F24Q24618546-5D3A1593-B676-4DCF-B76C-EADCBC549CD3Q27006565-D6374397-B755-4EA9-8FD6-3EFF44046920Q27309062-C3205DFA-FFF3-40E3-9363-D87BFCC46A84Q28070094-39284217-DEA0-4646-8C51-8D2CC94795D1Q28083733-FD2148E6-395F-4663-B483-F296803C50FFQ28385018-79FBDA6A-2CFC-4358-9B82-34F1C9311A0FQ28390828-D366B082-6071-450A-B8BC-3DACC831FECDQ28393653-5D950FD7-F27B-4FAF-A2D0-8BBA71A498ABQ28394109-E29A290E-2430-4802-93CC-10FE11AAD38DQ33579016-36670CF3-3EAB-4FD9-ABDA-1F2341114446Q33706866-F717074C-2A14-4801-93F9-328CF8454AC0Q34056304-08A861B2-D4ED-4476-A0A6-678EDF3D7A1EQ34077093-9A44F14F-ED8D-4843-B811-BDD325483D6CQ34218604-EE7E9ACD-FED4-4F9F-AEE6-931396B632B1Q34580323-CF47111D-BB4E-4317-B3DF-7CDFB6BF63D7Q34857355-B56915BE-28CF-47A9-8276-574A6A6F2E10Q34995163-46C9588A-0D6D-4ECE-9DCE-D05287D89336Q35035253-FF58247D-D63E-48F5-A577-A665052FEDFCQ35046046-0D3409D7-087B-4635-831F-3D72B1EE5622Q35049443-486168CA-5F8A-40A7-A3C7-4909C2A54421Q35054029-124D2394-DB4D-4DE6-9803-02DE77D3C700Q35121499-7832061D-B296-4F9F-90F5-9DF1C877820CQ35223657-F476693B-A760-4CD8-8476-CFB6D5537CACQ35272806-B968D470-4D5E-4326-822A-35923EF9159EQ35532761-B5740B65-1FFB-44C9-BE87-F21255DA6A0BQ35536149-79FF9853-6AA1-44E2-9742-77B903BD2552Q35628723-018D8FA2-E099-418B-B4BE-E5FDF69F659DQ35766783-7955A23E-9020-4AFC-A58B-60E37473944CQ35872012-10DE0520-32D1-472E-8D57-B5C08F60CC71Q35972946-6BB07E8F-D862-4951-AD49-81F6C8DA7211Q36016422-15A7C49B-6528-4A1A-8F6F-E4FD4D5C6C61Q36027111-415CC8E5-D251-4F63-A102-9449192E34A3Q36192785-21C40579-CE15-4098-AFBC-BFA2411B5FA9Q36237168-236319D6-926D-44BC-89CA-F37F6641CB14Q36304913-3118407B-4879-4643-9010-A48CF9C08321Q36382156-50568FD3-8BF9-4484-BE0E-093183B6D70FQ36414300-9617BF38-1885-4A05-9BCF-F489417765D4Q36659528-25EE1B2F-E8E2-4ACD-B0DB-FDFC06C596F7Q36692041-27C4BAFE-860D-4B1C-90D1-2AE7AF3732F2
P2860
Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Alternatively activated alveol ...... acellular signal transduction.
@en
Alternatively activated alveol ...... acellular signal transduction.
@nl
type
label
Alternatively activated alveol ...... acellular signal transduction.
@en
Alternatively activated alveol ...... acellular signal transduction.
@nl
prefLabel
Alternatively activated alveol ...... acellular signal transduction.
@en
Alternatively activated alveol ...... acellular signal transduction.
@nl
P2093
P50
P1433
P1476
Alternatively activated alveol ...... acellular signal transduction.
@en
P2093
Antje Prasse
Florian Kollert
Jan Dentler
Joachim Müller-Quernheim
Karlheinz Friedrich
Kathrin M Y Engel
Werner Luttmann
P304
P356
10.1016/J.CLIM.2010.06.017
P577
2010-07-31T00:00:00Z